Related Experiment Video
Updated: Sep 13, 2026

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
Published on: August 9, 2024
Treatment charges and resource use among patients with heart failure enrolled in an MCO
Gregory de Lissovoy1, Marc Zodet, Karen Coyne
1MEDTAP International, Bethesda, Maryland, USA.
Insights
Hospital admission for heart failure (HF) significantly increases annual treatment costs by 98%. Expenditures rose substantially post-admission, regardless of patient age, highlighting the economic burden of HF care.
Area of Science:
- Health Economics
- Cardiology
- Healthcare Management
Background:
- Heart failure (HF) is a significant public health concern with substantial economic implications.
- Understanding patient-level expenditures associated with HF is crucial for resource allocation and healthcare policy.
Purpose of the Study:
- To determine patient-level annual expenditures and resource utilization for heart failure (HF).
- To analyze the change in annual expenditure following a hospital admission for HF.
Main Methods:
- Retrospective analysis of administrative claims data from 899 adult patients (40-74 years) continuously enrolled in an IPA-model MCO.
- Data collected for the period 1996-1998, focusing on individuals with a primary HF diagnosis during index hospitalization.
- Analysis stratified by age groups and pre-index expenditure quintiles.
Main Results:
- Median annual charges increased by 98% (from $6,026 pre-event to $14,292 post-event) after HF hospitalization.
- Mean annual charges saw a 105% increase post-event.
- One-year readmission rates varied from 30% in the lowest expenditure quintile to 63% in the highest.
- Expenditure and expenditure increase were not significantly related to patient age.
Conclusions:
- Hospital admission for heart failure is associated with a significant rise in treatment intensity and annual healthcare expenditure.
- While HF prevalence increases with age, patient-level treatment costs remain comparable across different age groups.
- Healthcare systems should anticipate and plan for increased resource utilization following HF admissions.
Abstract:
The purpose of this study was to determine patient-level annual expenditures and resource use for heart failure (HF) and change in annual expenditure after a hospital admission for HF. The study population comprised members of an IPA-model MCO (N = 899) who were 40 to 74 years old and continuously enrolled for at least six months before and after an index hospital admission with a primary diagnosis of HF. A retrospective analysis was conducted of administrative claims data between 1996 and 1998. Analysis was stratified by five-year age groups and by quintiles created by rank-ordering individuals according to their pre-index annualized expenditure and then dividing the cohort into five equal groups. During the year before the index HF event, median annualized charges were $6,026 (mean +/- SD, $17,490 +/- $32,234), and median postevent charges were $14,292 (mean, $35,780 +/- $60,881), a 98% increase in median (105% increase in mean). Age was unrelated to average annual expenditure or to increase in expenditure after the index event. One-year readmission rates ranged from 30% (95% confidence interval [CI], 35%-51%), for patients in the least costly quintile, to 63% for the most costly quintile (95% CI, 55%-71%). Although HF prevalence increases with age, patient-level treatment expenditures are comparable across age groups. Hospital admission for HF is associated with a substantial increase in treatment intensity and annual expenditure.
More Related Videos
03:47Workflow and Framework for Collecting and Implementing Point-of-Care Ultrasound Data in the Management of Heart Failure Patients
Published on: July 12, 2024
05:16Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
Related Concept Videos
Heart Failure Drugs: Inotropic Agents
Heart Failure IV: Classification and Diagnostic Evaluation
Heart Failure V: Medical Management
Heart Failure VI: Adjunct Therapies
Heart Failure VII: Nursing Interventions
Cardiomyopathy V: Interprofessional Care